Volinia, Stefano
University of Warsaw,
Poland
2025 Rank: 69943
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2841 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69943 | 76445 |
| Total Cites | 47655 | 51585 |
| H-index | 85 | 91 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 6144 | 6530 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 7006 | 7453 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 33933 | 35613 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.45 |
| Self-Citation Percentage |
7.62%
|
|
Volinia, Stefano
University of Ferrara,
Italy
2024 Rank: 65161
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2709 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65161 | 72398 |
| Total Cites | 46411 | 50266 |
| H-index | 84 | 89 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 6017 | 6395 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 6823 | 7262 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 32888 | 34543 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.46 |
| Self-Citation Percentage |
7.67%
|
|
Volinia, Stefano
University of Ferrara,
Italy
2023 Rank: 61199
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2597 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61199 | 67832 |
| Total Cites | 45055 | 48851 |
| H-index | 83 | 88 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5862 | 6237 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 6597 | 7031 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 31792 | 33402 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.46 |
| Self-Citation Percentage |
7.77%
|
|
Volinia, Stefano
University of Ferrara,
Italy
2022 Rank: 56918
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2434 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56918 | 63337 |
| Total Cites | 43087 | 46781 |
| H-index | 82 | 86 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5637 | 6007 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 6262 | 6691 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 30225 | 31789 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.47 |
| Self-Citation Percentage |
7.90%
|
|
Volinia, Stefano
University of Ferrara,
Italy
2021 Rank: 54785
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2368 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54785 | 60775 |
| Total Cites | 41987 | 45594 |
| H-index | 80 | 85 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5527 | 5892 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 6101 | 6520 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 29354 | 30877 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.48 |
| Self-Citation Percentage |
7.91%
|
|
Volinia, Stefano
University of Ferrara,
Italy
2020 Rank: 51620
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2315 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51620 | 57483 |
| Total Cites | 39384 | 42897 |
| H-index | 78 | 82 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5210 | 5566 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 5653 | 6062 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 27231 | 28697 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.49 |
| Self-Citation Percentage |
8.19%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.